Geneos Wealth Management’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,130
Closed -$103K 2785
2021
Q3
$103K Hold
1,130
﹤0.01% 1161
2021
Q2
$139K Sell
1,130
-118
-9% -$11.6K 0.01% 1019
2021
Q1
$120K Hold
1,248
﹤0.01% 1211
2020
Q4
$100K Buy
+1,248
New +$93K ﹤0.01% 1143

Other funds holding CRNC

Geneos Wealth Management's CRNC Position: Q4 2021 in Review

Geneos Wealth Management sold out of Cerence (CRNC) in Q4 2021, closing a stake of 1,130 shares — an estimated $103K sold.

Geneos Wealth Management first reported a position in CRNC in Q4 2020 and held it in 4 quarters. The position peaked at $139K in Q2 2021. 360 funds tracked by Wall St. Rank hold CRNC as of Q4 2021.

  • Geneos Wealth Management reported no remaining Cerence position as of Q4 2021 after selling out during the quarter.
  • Geneos Wealth Management sold 1,130 Cerence shares in Q4 2021, an estimated $103K.
  • Geneos Wealth Management first reported a position in Cerence in Q4 2020 and held it in 4 quarters.
  • Geneos Wealth Management's Cerence position peaked at $139K in Q2 2021.
  • 360 funds tracked by Wall St. Rank held Cerence as of Q4 2021.

Based on Geneos Wealth Management's 13F filing for Q4 2021, filed 9 Feb 2022.